Bertil Lindmark Galecto, Inc. (GLTO) insider trading activity
Bertil Lindmark is Chief Medical Officer of Galecto, Inc.. Currently has a direct ownership of 16,604 shares of GLTO, which is worth approximately $82,355. The most recent transaction as insider was on Mar 22, 2022, when has been sold 14,604 shares (Common Stock) at a price of $2.16 per share, resulting in proceeds of $31,545. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
16.6K
0%
3M change
0%
12M change
Total Value Held
$82,355
Bertil Lindmark Transaction History
BL
Bertil Lindmark
Chief Medical Officer
Copenhagen N, G7